Table 1 SRSF2 mutations in chronic myelomonocytic leukemia
From: SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
Reference | Disease | Frequency of SRSF2 mutation | Effect on Survival | Effect on disease progression |
|---|---|---|---|---|
[8] | CMML | 28.4% | NR | NR |
[42] | CMML | 47% (129/275) | No | No |
[53] | CMML | 46% (173/409) | NR | NR |
[41] | CMML | 40% (90/226) | No | No |
[43] | CMML | 28% | NR | NR |
[64] | CMML | 20% (1/5) | NR | NR |
[26] | CMML | 32% (28/87) | No | NR |
[77] | CMML (Chinese population) | 20% (10/50) | No | No |
[45] | CMML | 44% (16/36) | No | NR |
[57] | CMML (aged < 65 years) | 45% (72/161) | Yes | No |
[58] | CMML | 25% (14/56) | Yes | Yes |
[27] | CMML | 46% (143/312) | Yes | Yes |
[56] | CMML | 40% (90/226) | No | No |
[52] | CMML | 45% (116/274 | NR | No |
[54] | CMML | 51% (74/146) | NR | NR |
[67] | CMML | 53% (31/58) | NR | NR |